Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

Topic

Health

Utilities consumer staples and healthcare
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities

Here's what you need to know about the three defensive sectors in the S&P 500

Latest news about Health

Obesity and Weight-Loss Drugs: A New Thematic ETF Segment?

The ongoing Ozempic and weight-loss drug obsession has investors and ETF issuers turning to new ways of gaining healthcare sector exposure.

Weight-loss-drugs

Healthcare Stocks Drop on Medicare Payment Rate Surprise

Shares of major U.S. health insurers have taken a significant hit as the final 2025 Medicare Advantage plan payment rates fall short of industry expectations, raising concerns about margins.

Healthcare ETFs drop

Notable ETF Filings Recap: March 2024

Here's a look at some of the most interesting prospective ETFs awaiting regulatory review and approval as of March.

Files and documents piles

Healthcare Funds on the Rise

Health Care sector sees a modest 2023 finish after a decline in 2022, sparking renewed interest with substantial inflows this week.

refill of liquid on tubes

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Ozempic, Wegovy, and Mounjaro – here's how the latest weight-loss drugs could affect some pharmaceutical and food ETFs.

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Dr. Sasha Goodman, Chief Investment Officer of VegTech Invest, joins Elysabeth Alfano, CEO of VegTech Invest to discuss what has happened to the Beyond Meat and Oatly stocks and, conversely, the large landscape of Plant-based Innovation companies in the public markets that are thriving.

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Two biotech ETFs to watch for the rest of 2022 and beyond

Investors with a high tolerance for risk may seek to gain exposure to the growth potential of the biotech industry. We take a look at two ETFs that have rallied over the last month.

Two biotech ETFs to watch for the rest of 2022 and beyond
Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

PRIV ETF

What’sTheFund

What's the Fund | State Street SPDR IG Public & Private Credit ETF (Ticker: PRIV)

Matthew Bartolini, Global Head of Research Strategists, at State Street Investment Management, joins Ethan Hertzfeld on the New York Stock Exchange Floor to discuss PRIV, the State Street SPDR IG Public & Private Credit ETF.

NYSE logo
By NYSE · April 28, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 27, 2026

The ETF Industry saw 23 New Launches, 1 Ticker Change and 4 closures last week.

Tidal
By Tidal · April 28, 2026
Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Asset TV

The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.

Asset TV
By Asset TV · April 22, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 20, 2026

The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.

Tidal
By Tidal · April 22, 2026

Browse all educational columns

ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder